[Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D010936:Plant Extracts / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010936:Plant Extracts; D004176:Dipyridamole; D001241:Aspirin
Gehtraining und konservative Behandlung. Leitsätze für die Pharmakotherapie der chronischen peripheren arteriellen Verschlusskrankheit (Stadien I und IIb).